Clinical Trial Search

Primary: Change From Baseline to Week 12 in the Severity of Vaginal Dryness — 15; 13; 13; 9 Participants — p==0.304

Primary: Change of Endothelial Function by Measurement of Flow-mediated Vasodilation Using the Reactive Hyperemia Index (RHI) — 2.20; 2.17; 1.56; 2.08 score on a scale — p=0.052

Primary: Change in Days of Unhealthy Alcohol Consumption — 5.46; 7.16; 2.72; 5.56 Unhealthy drinking days in last 30

Primary: Total HIV DNA From CD4 T-cells — 2.95; 3.06 HIV-DNA copies/mill CD4+ T cells (log10) — p=0.26

Primary: Rate of Development of Unit-acquired Pressure Ulcers — 45; 42 Participants

Primary: Percentage of Participants With at Least 50% Reduction From Baseline in the Number of Draining Perianal Fistulae (of Those Draining at Baseline) — 75.0; 75.0 percentage…

Primary: Percentage of Participants With Positive Responses in Virus-specific Antibody in Sera — 80; 75; 100; 100 percentage of participants

Primary: Percentage of Participants With One or More Adverse Events — 15; 18 Participants

Primary: Number of Patients With Reactions of the Injection Site as an Assessment of the Tolerability — 3 Participants

Primary: 3 Month Compliance With the Kurbo App as Well as the Kurbo App and PHC by a Group of Morbidly Obese Children and Adolescents in a Weight Management Program. — 0; 14; 0…

Primary: Binocular Defocus Curve at Month 3 — 0.539; 0.364; 0.213; 0.054 logMAR

Primary: Change in Fat Mass With Caffeine/Albuterol — 0.97; -0.21 kg

Primary: Number of Participants Completing Secondary School [Sit 10th Standard Exam] — 680; 658 Participants — p=0.98

Primary: Solicited Local Reactogenicity Symptoms for Participants Given Adjuvant AS03 — 42; 44; 36 Participants

Primary: Subject Response Rates for PRNT80 Titers — 39; 28; 48; 79 Participants